GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.

In conclusion, GRHL2/ZEB1 axis inhibits CRC progression and metastasis via oppressing EMT. PMID: 31063022 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31063022?dopt=Abstract

Source: Cancer Biology and Therapy - May 6, 2019 Category: Cancer & Oncology Authors: Yang Z, Wu D, Chen Y, Min Z, Quan Y Tags: Cancer Biol Ther Source Type: research